Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers
Preprint
Abstract
Background: Bloom Syndrome (BSyn) is an autosomal recessive disorder caused by biallelic germline variants in BLM, which functions to maintain genomic stability. BSyn patients have poor growth, immune defects, insulin resistance, and a significantly increased risk of malignancies, most commonly hematologic. The malignancy risk in carriers of pathogenic variants in BLM ( BLM variant carriers) remains understudied. Clonal hematopoiesis of indeterminate potential (CHIP) is defined by presence of somatic mutations in leukemia-related genes in blood of individuals without leukemia and is associated with increased risk of leukemia. We hypothesize that somatic mutations driving clonal expansion may be an underlying mechanism leading to increased cancer risk in BSyn patients and BLM variant carriers. Methods: To determine whether de novo or somatic variation is increased in BSyn patients or carriers, we performed and analyzed exome sequencing on BSyn and control trios. Results: We discovered that both BSyn patients and carriers had increased numbers of low-frequency, putative somatic variants in CHIP genes compared to controls. Furthermore, BLM variant carriers had increased numbers of somatic variants in DNA methylation genes compared to controls. There was no statistical difference in the numbers of de novo variants in BSyn probands compared to control probands. Conclusion: Our findings of increased CHIP in BSyn probands and carriers suggest that one or two germline pathogenic variants in BLM could be sufficient to increase the risk of clonal hematopoiesis. These findings warrant further studies in larger cohorts to determine the significance of CHIP as a potential biomarker of aging, cancer, cardiovascular disease, morbidity and mortality.Keywords
All Related Versions
- Published version: Haematologica, 110 (1), 187.
This publication has 78 references indexed in Scilit:
- Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility AllelesPLOS Genetics, 2012
- Rate of de novo mutations and the importance of father’s age to disease riskNature, 2012
- High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in RussiaInternational Journal of Cancer, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- The Bloom's syndrome helicase suppresses crossing over during homologous recombinationNature, 2003
- Functional Relation among RecQ Family Helicases RecQL1, RecQL5, and BLM in Cell Growth and Sister Chromatid Exchange FormationMolecular and Cellular Biology, 2003
- BLM Heterozygosity and the Risk of Colorectal CancerScience, 2002
- Enhanced Tumor Formation in Mice Heterozygous for Blm MutationScience, 2002
- The Ashkenazic Jewish Bloom Syndrome Mutation blmAsh Is Present in Non-Jewish Americans of Spanish AncestryThe American Journal of Human Genetics, 1998
- Carrier Frequency of the Bloom SyndromeblmAshMutation in the Ashkenazi Jewish PopulationMolecular Genetics and Metabolism, 1998